A detailed history of Brown, Lisle/Cummings, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 6,727 shares of TMO stock, worth $3.45 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
6,727
Previous 6,427 4.67%
Holding current value
$3.45 Million
Previous $3.55 Billion 17.08%
% of portfolio
1.26%
Previous 1.16%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$531.86 - $624.21 $159,558 - $187,263
300 Added 4.67%
6,727 $4.16 Billion
Q2 2024

Jul 17, 2024

BUY
$541.52 - $599.02 $8,122 - $8,985
15 Added 0.23%
6,427 $3.55 Billion
Q1 2024

Jun 28, 2024

BUY
$528.82 - $599.43 $190,375 - $215,794
360 Added 5.95%
6,412 $3.73 Billion
Q4 2023

Jun 28, 2024

BUY
$431.41 - $532.94 $75,496 - $93,264
175 Added 2.98%
6,052 $3.21 Billion
Q3 2023

Jun 28, 2024

BUY
$498.29 - $574.41 $71,753 - $82,715
144 Added 2.51%
5,877 $2.97 Billion
Q2 2023

Jun 28, 2024

BUY
$508.46 - $591.13 $119,488 - $138,915
235 Added 4.27%
5,733 $2.99 Billion
Q1 2023

Jun 28, 2024

SELL
$535.0 - $604.82 $26,750 - $30,241
-50 Reduced 0.9%
5,498 $3.17 Billion
Q4 2022

Jun 28, 2024

BUY
$484.71 - $571.37 $126,509 - $149,127
261 Added 4.94%
5,548 $3.06 Billion
Q3 2022

Jun 28, 2024

SELL
$507.19 - $604.49 $17,751 - $21,157
-35 Reduced 0.66%
5,287 $2.68 Billion
Q2 2022

Jun 28, 2024

SELL
$500.9 - $612.21 $70,126 - $85,709
-140 Reduced 2.56%
5,322 $2.89 Billion
Q1 2022

Jun 28, 2024

BUY
$524.0 - $644.92 $68,120 - $83,839
130 Added 2.44%
5,462 $3.23 Billion
Q4 2021

Jun 28, 2024

BUY
$569.0 - $667.24 $3.03 Million - $3.56 Million
5,332 New
5,332 $3.56 Billion

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Brown, Lisle/Cummings, Inc. Portfolio

Follow Brown, Lisle/Cummings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown, Lisle/Cummings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brown, Lisle/Cummings, Inc. with notifications on news.